Many companies have taken the position that their products have no GMOs. In the United States, foods that contain ingredients derived from corn, soy, canola, and sugar beets have usually been genetically modified. Sixty-four countries around the world have required that GMO foods be labeled. A 2015 survey from ABC News founds that 93% of Americans believe that GMO foods should be labeled.
On the other hand, many scientists and political leaders have argued that the use of GMOs has permitted the United States to grow more food, food that supplies those who are starving throughout the world. Former Governor Mitch Daniels of Indiana maintains that the intentional starvation of people is callous and cruel, but he also believes that denying the world the benefits of increased food production from GMOs carries no moral distinction in resulting starvation.
There are scientific concerns about the effects of GMOs on the environment and on humans when they ingest the food.
If you were on the board of a company that is faced with using GMO or non-GMO suppliers, discuss what position Milton Friedman might take on this issue.
Using the facts in question 1, discuss how Edward Freeman would address the issue the company faces.
Andy Puzder, once a candidate for secretary of labor in the Trump administration, has written, "When a store closes, the minimum wage for your lost job is zero." Mr. Puzder believes that increases in minimum wage destroy jobs and hurt working class Americans. What readings and cases in Unit 3 provide support for Mr. Puzder's view? Which readings and cases would take a different view?
Who are the stakeholders in those situations in which pharmaceutical companies substantially increase the prices of their drugs?
The Ethical Dilemma of GMOs in Food Production
Thesis Statement
In the debate over the use of genetically modified organisms (GMOs) in food production, the ethical considerations surrounding their potential benefits in addressing global hunger versus the environmental and health concerns they raise present a complex issue. This essay will explore the perspectives of influential thinkers such as Milton Friedman, Edward Freeman, and Andy Puzder on this contentious topic.
Introduction
The use of GMOs in food production has sparked a contentious debate, with advocates highlighting increased food supply to combat global hunger, while critics raise concerns about environmental impact and potential health risks. This essay delves into the ethical dimensions of this dilemma, considering the viewpoints of prominent figures in the field of ethics and economics.
Milton Friedman's Perspective
Milton Friedman, a renowned economist and proponent of free-market capitalism, would likely take a pragmatic stance on the GMO issue. Friedman's ideology prioritized economic efficiency and individual choice. In the context of GMOs, he might argue that companies should have the freedom to choose suppliers based on cost-effectiveness and consumer demand. From Friedman's perspective, if GMOs enable increased food production at a lower cost, thereby benefiting consumers, then companies should have the liberty to opt for GMO suppliers.
Edward Freeman's Approach
Edward Freeman, known for his work on stakeholder theory, would approach the GMO dilemma by considering the interests of all stakeholders involved. In this case, Freeman would advocate for companies to engage with various stakeholders, including consumers, environmental groups, and health experts, to make informed decisions about GMO usage. Freeman would emphasize the importance of corporate social responsibility and ethical decision-making that takes into account not only financial considerations but also broader societal impacts.
Andy Puzder's Contention
Andy Puzder's perspective on the minimum wage provides insight into his potential stance on GMOs. Puzder's belief that minimum wage increases lead to job losses aligns with a broader economic argument against regulatory measures that impact business operations. Applying this viewpoint to GMOs, Puzder might argue against stringent regulations on GMO labeling or production, citing concerns about potential economic repercussions for companies and consumers.
Stakeholders in Pharmaceutical Pricing
In the context of pharmaceutical pricing, stakeholders include not only the companies themselves but also patients, healthcare providers, insurers, and regulatory bodies. When pharmaceutical companies substantially increase drug prices, patients may face financial burdens, healthcare providers may encounter challenges in treatment decisions, and regulators may need to assess affordability and access issues. Balancing the interests of these stakeholders presents another ethical dilemma in the realm of healthcare economics.
Conclusion
The ethical considerations surrounding the use of GMOs in food production encompass a range of perspectives, from economic efficiency to stakeholder interests and regulatory impacts. By examining the viewpoints of thinkers like Friedman, Freeman, and Puzder, as well as considering stakeholders in pharmaceutical pricing, we can better understand the complex ethical dilemmas that arise in the intersection of business, economics, and public health. Ultimately, navigating these dilemmas requires a nuanced approach that considers both short-term benefits and long-term consequences for society as a whole.